Literature DB >> 8505641

MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment.

R E Ferner1, R Chaudhuri, J Bingham, T Cox, R A Hughes.   

Abstract

Thirty eight patients with neurofibromatosis 1 (NF1) had neurological examinations, intellectual assessments and MRI scans. Increased intensity lesions on T2 weighted images were found in 13 patients. These abnormalities were more common in patients aged under 18 years. The lesions occurred predominantly in the basal ganglia, brainstem and cerebellum, and were multiple in 11 patients. They did not produce symptoms or neurological deficit in any patient and did not enhance with gadolinium-meglumine-triamine-pentaacetic acid contrast medium (Gd-DTPA). In 2 patients, however, the abnormalities exerted mass effect distorting the brain and in 3 patients they occurred in conjunction with known gliomas. The lesions remained unchanged over a three year follow up period. The nature of the lesions is uncertain but the fact that they may produce mass effect and occur in association with gliomas suggests that they have malignant potential. There was no correlation between the presence of these abnormalities and intellectual impairment.

Entities:  

Mesh:

Year:  1993        PMID: 8505641      PMCID: PMC1015007          DOI: 10.1136/jnnp.56.5.492

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.

Authors:  S A Mirowitz; K Sartor; M Gado
Journal:  AJR Am J Roentgenol       Date:  1990-02       Impact factor: 3.959

2.  The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect.

Authors:  N P Rosman; J Pearce
Journal:  Brain       Date:  1967-12       Impact factor: 13.501

3.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

4.  A new sign of neurofibromatosis on magnetic resonance imaging of children.

Authors:  S M Goldstein; R G Curless; M J Donovan Post; R M Quencer
Journal:  Arch Neurol       Date:  1989-11

5.  Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis.

Authors:  D W Dunn; K L Roos
Journal:  Neurofibromatosis       Date:  1989

6.  von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

Authors:  R A Lewis; L P Gerson; K A Axelson; V M Riccardi; R P Whitford
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

7.  Cranial MR imaging in neurofibromatosis.

Authors:  J R Bognanno; M K Edwards; T A Lee; D W Dunn; K L Roos; E C Klatte
Journal:  AJR Am J Roentgenol       Date:  1988-08       Impact factor: 3.959

8.  The significance of MRI abnormalities in children with neurofibromatosis.

Authors:  P K Duffner; M E Cohen; F G Seidel; D W Shucard
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

9.  MR of neuronal migration anomalies.

Authors:  A J Barkovich; S H Chuang; D Norman
Journal:  AJR Am J Roentgenol       Date:  1988-01       Impact factor: 3.959

  9 in total
  22 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

2.  Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1.

Authors:  Rony Cohen; Tamar Steinberg; Liora Kornreich; Sharon Aharoni; Ayelet Halevy; Avinoam Shuper
Journal:  Eur J Pediatr       Date:  2014-07-16       Impact factor: 3.183

3.  Age-related findings on MRI in neurofibromatosis type 1.

Authors:  Deepak S Gill; Shelley L Hyman; Adam Steinberg; Kathryn N North
Journal:  Pediatr Radiol       Date:  2006-08-16

Review 4.  [Neurofibromatoses].

Authors:  A Zimmer
Journal:  Radiologe       Date:  2013-12       Impact factor: 0.635

Review 5.  Neurocognitive dysfunction in children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 6.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

Review 7.  Psychological aspects of von Recklinghausen neurofibromatosis (NF1)

Authors:  S E Mouridsen; S A Sørensen
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

Review 8.  Special issues in the management of gliomas in children with neurofibromatosis 1.

Authors:  I F Pollack; J J Mulvihill
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

9.  Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.

Authors:  E Legius; M J Descheemaeker; J Steyaert; A Spaepen; R Vlietinck; P Casaer; P Demaerel; J P Fryns
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

10.  Reduced cerebral arterial spin-labeled perfusion in children with neurofibromatosis type 1.

Authors:  K W Yeom; R M Lober; P D Barnes; C J Campen
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.